Type
. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. Journal of immunology (Baltimore, Md. : 1950) [Internet]. 2005;175(12):7930-8. Available from: http://www.jimmunol.org/content/175/12/7930.full.pdf+html
Type
. [Leprosy: the reality for adolescents]. Revista brasileira de enfermagem. 2005;58(3):296-301.
Type
. Detection of neuropathy due to Mycobacterium leprae using noninvasive neurosensory testing of susceptible peripheral nerves. Annals of plastic surgery. 2005;55(6):633-7.
Type
. AIDS and HIV infections: uncommon presentations. Clinics in dermatology. 2005;23(6):572-80.
Type
. [Dermopathy and peripheral neuropathy]. Enfermedades infecciosas y microbiologia clinica. 2005;23(10):629-30.
Type
. Ethical issues considered in Tamil Nadu leprosy vaccine trial. Issues in medical ethics. 2000;8(1):10-2.
Type
. Leprosy: contribution of mast cells to epineurial collagenization. Clinical neuropathology. 2005;24(6):284-90.
Type
. Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye (London, England) [Internet]. 2005;19(10):1099-105. Available from: http://www.nature.com/eye/journal/v19/n10/pdf/6701984a.pdf
Type
. [Serological tests in the diagnosis of tuberculosis]. Biomedica : revista del Instituto Nacional de Salud. 2005;25(3):422-3; author reply 423-4.
Type
. [Dermatologic manifestations associated with immune reconstitution syndrome in HIV+ patients starting HAART: a retrospective study in French Guiana]. Bulletin de la Societe de pathologie exotique (1990). 2005;98(3):187-92.